Digital Evidence Base

Trusted Knowledge for Informed Decisions

Filters
SDGs
Priority Areas
Research Outcomes
Document Type
Year
4019 results found
Show:
A demonstration of mobile phone deployment to support the treatment of acutely ill children under five in Bushenyi district, Uganda
Maling S, Kabakyenga J, Kyomuhangi T, Barigye C, Brenner J, Buchner D, Nettle-Aquirre A, Singhal N, Tumusiime D, Finch J, MacLeod S
2016
DOI: 10.4314/ahs.v16i1.12

Background: Benefits of mobile phone deployment for children <5 in low-resource settings remain unproven. The target population of the current demonstration study in Bushenyi District, Uganda, presented with acute fever, …

Abstract
Analysis of the Leprosy Agents Mycobacterium leprae and Mycobacterium lepromatosis in Four Countries
Han XY, Aung FM, Choon SE, Werner B
2014
DOI: 10.1309/AJCP1GLCBE5CDZRM

Objectives: To differentiate the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis nd correlate them with geographic distribution and clinicopathologic features.Methods: Species-specific polymerase chain reactions were used to detect each bacillus …

Abstract
Effects of Physical Activity on Breast Cancer Prevention: A Systematic Review
Gonçalves Ana Katherine, Dantas Florêncio Gilzandra Lira, de Atayde Silva Maria José Maissonnete, Cobucci Ricardo Ney, Giraldo Paulo César, Cote Nancy Michelle
2014

Background: Observational studies have reported an association between physical activity and breast cancer risk reduction. This study aims to evaluate the effect of physical activity on breast cancer prevention. Methods: …

Abstract
What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism
ACTwatch Grp, Hanson K, Goodman C, Tougher S
2017
DOI: 10.1186/s12936-017-1814-z

Background: The private sector supplies anti-malarial treatment for large proportions of patients in sub-Saharan Africa. Following the large-scale piloting of the Affordable Medicines Facility-malaria (AMFm) from 2010 to 2011, a …

Abstract
The role, impact, and support of informal caregivers in the delivery of palliative care for patients with advanced cancer: A multi-country qualitative study
Adejoh SO, Boele F, Akeju D, Dandadzi A, Nabirye E, Namisango E, Namukwaya E, Ebenso B, Nkhoma K, Allsop MJ
2021
DOI: 10.1177/0269216320974925

Background:Cancer is increasing in its prevalence in sub-Saharan Africa. Informal caregivers are key to supporting engagement and interaction with palliative care services, but limited literature on their role impedes development …

Abstract
Evaluating capacity-building for mental health system strengthening in low- and middle-income countries for service users and caregivers, service planners and researchers
Hanlon C, Jordans M, Petersen I, Shidhaye R, Thornicroft G, Semrau M, Alem A, Abayneh S, Abdulmalik J, Docrat S, Evans-Lacko S, Gureje O, Lempp H, Mugisha J
2018
DOI: 10.1017/S2045796017000440

Efforts to support the scale-up of integrated mental health care in low- and middle-income countries (LMICs) need to focus on building human resource capacity in health system strengthening, as well …

Abstract
STRENGTHENING HEALTH CARE SYSTEMS: PRIVATE FOR-PROFIT COMPANIES' CORPORATE SOCIAL RESPONSIBILITY ENGAGEMENTS
Katamba David
2017

This paper contributes to The Post-2015 MDG agenda and the Rio+20 outcome document, The Future We Want, by exploring and providing guiding frameworks for how private for-profit companies (PFPCs) can …

Abstract
Integrating a Parenting Intervention With Routine Primary Health Care: A Cluster Randomized Trial
Florencia Lopez-Boo, Helen Baker-Henningham, Susan P Walker
2015

OBJECTIVE: More than 200 million children globally do not attain their developmental potential. We hypothesized that a parent training program could be integrated into primary health center visits and benefit …

Abstract
Apabetalone downregulates fibrotic, inflammatory and calcific processes in renal mesangial cells which may contribute to reduced cardiac events observed in ckd patients
Gilham D., Fu L., Rakai B., Wasiak S., Tsujikawa L., Halliday C., Sarsons C., Stotz S., Jahagirdar R., Johansson J., Sweeney M., Wong N., Kalantar-Zadeh K., Kulikowski E.
2021
DOI: 10.1093/ndt/gfab078.008

BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …

Abstract
AI Research Assistant
AI-powered research assistance. Uses the Digital Evidence Base as the Knowledge source.